Anteris Technologies Global Corp. — Board/Management Information 2018

Oct 30, 2018

31.10.18

==> picture [453 x 24] intentionally omitted <==

ASX ANNOUNCEMENT

NON-EXECUTIVE DIRECTOR AND COMPANY SECRETARY APPOINTMENT

Admedus Limited (ASX:AHZ) (“the Company”) announces the appointment of Mr Steve Denaro to its Board of Directors as a Non-Executive Director and Company Secretary, effective immediately.

Mr Denaro is a Chartered Accountant and Registered Tax Agent with more than thirty years of senior and Board level experience across publicly-listed companies; serving as Chief Financial Officer, Company Secretary and Director.

He brings to Admedus, a depth of experience in managing compliance with finance and accounting regulatory requirements. Mr Denaro has managed investment acquisitions and subsequent funding (domestic and international), and has a proven track record in corporate equity, treasury and debt funding management.

Admedus Chairman, John Seaberg, welcomed Mr Denaro to the Board;

“We are very pleased to welcome Steve to the Admedus Board. His comprehensive experience in financial management and deep understanding of the Australian and global financial regulatory environments make him a valuable addition to the Company’s leadership as we pursue exciting new strategic opportunities.”

Mr Denaro will perform the duties of Company Secretary pursuant to the terms of a Consultancy Agreement entered into between Mr Denaro and the Company. A summary of the key terms of that Consultancy Agreement are:

• Appointment is from 31 October 2018;

• The appointment is ongoing, no fixed term, with either party being able to terminate the Consultancy Agreement by written notice; and

• Mr Denaro will be paid $50,000 per annum excluding GST for time spent performing the role of Company Secretary.

Attached is an Appendix 3X (Initial Director’s Interest Notice) for Mr Denaro.

Admedus Limited Registered Office: Level 9, 301 Coronation Drive, Milton, Queensland 4064

T: 1300 550 310 F: 1300 880 398 International: T: +61 (0)7 3152 3200 F: +61 (0)7 3152 3299 E: info@admedus.com W: admedus.com

==> picture [72 x 72] intentionally omitted <==

Customer Service:

Brisbane • Minneapolis • Geneva • Singapore

ABN 35 088 221 0

About Admedus Limited

Admedus (ASX:AHZ) is a medical technologies company delivering clinically superior solutions that help healthcare professionals create life-changing outcomes for patients. Our focus is on investing in and developing next generation technologies with world class partners, acquiring strategic assets to grow product and service offerings and expanding revenues from our existing medical sales and distribution business. The company has assets from research & development through clinical development as well as sales, marketing and distribution.

Website: www.admedus.com Facebook: www.facebook.com/Admedus Twitter: @Admedus

For more information, please contact:

Admedus@we-buchan.com

==> picture [21 x 19] intentionally omitted <==

Appendix 3X Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/9/2001.

Admedus Limited 088 221 078

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Steve Denaro
Date of appointment	31 October 2018

Part 1 - Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

NIL

• See chapter 19 for defined terms.

Appendix 3X Page 1

11/3/2002

Appendix 3X Initial Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of	Number & class of Securities
interest	None
Note: Provide details of the circumstances giving
rise to the relevant interest.

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	None
Nature of interest
Name of registered holder
(if issued securities)
No. and class of securities to
which interest relates

• See chapter 19 for defined terms.

Appendix 3X Page 2

11/3/2002